How a specific receptor affects immune cells and healing in diabetes-related wounds
Role of pregnane x receptor activation on macrophage function and diabetic wound healing
This study is looking at how a specific receptor in the body affects immune cells that help heal wounds, especially for people with diabetes, to find new ways to improve healing and prevent issues like foot ulcers.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mississippi State University NIH-funded |
| Lab location | 1 site (Mississippi State, United States) |
| Project ID | NIH-10730438 on NIH RePORTER |
What this research studies
This research investigates how the activation of the pregnane x receptor (PXR) influences the function of immune cells called macrophages, which are crucial for wound healing, particularly in patients with diabetes. The study aims to understand the mechanisms by which environmental factors and certain chemicals can alter macrophage behavior, potentially leading to complications like diabetic foot ulcers. By exploring these interactions, the research seeks to identify new therapeutic strategies to enhance wound healing in diabetic patients. The approach involves both laboratory experiments and analysis of macrophage responses to various stimuli.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type 1 diabetes who are at risk of developing diabetic foot ulcers.
Not a fit: Patients without diabetes or those who do not have issues with wound healing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for diabetic foot ulcers, reducing the risk of complications such as limb amputation.
How similar studies have performed: Previous research has shown promising results in understanding macrophage function in wound healing, suggesting that this approach could yield valuable insights.
Where this research is happening
Mississippi State, United States
- Mississippi State University — Mississippi State, United States (Active)
Researchers
- Principal investigator: Howell, George E — Mississippi State University
- Study coordinator: Howell, George E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.